Related Experiment Videos
Widespread inhibition of neuroblastoma cells in the 13- to 17-day-old mouse embryo
Abstract:
Previous experiments have demonstrated specific inhibition of tumor formation after neuroblastoma cells were injected into fragments of 8.5- to 9.5-day embryonic tissue (A.H. Podesta et al. Proc. Natl. Acad. Sci. USA, 81:7608-7611, 1984). The effect was localized to the somite and appeared specific for neuroblastoma as opposed to a variety of other tumor types. This regulation of neuroblastoma cells was believed to reflect an underlying event in the development of migrating embryonic neuroblasts. The current experiments were done to determine the effect on regulation with further embryonic development. The results indicated that later embryos (13 to 17 days of gestation) have a widespread inhibitory effect in all tissues tested, including the adrenal gland, testis, kidney, liver, limb bud, and heart. In contrast a leukemia cell line was not affected by any of these tissues. In organ culture demonstrable colony formation by neuroblastoma was likewise inhibited, and conditioned media from one of these embryonic sources (limb bud) slowed but did not abrogate growth of neuroblastoma cells.
Insights
Later embryonic tissues inhibit neuroblastoma growth, unlike leukemia cells. This suggests embryonic development plays a role in regulating tumor cell proliferation.
Area of Science:
- Developmental Biology
- Cancer Research
- Cell Biology
Background:
- Previous studies showed early embryonic tissues (8.5-9.5 days) specifically inhibit neuroblastoma tumor formation.
- This inhibition was localized to the somite and suggested a link to embryonic neuroblast development.
- The mechanism and developmental stage-dependency of this regulatory effect remained unclear.
Purpose of the Study:
- To investigate the effect of later embryonic development on the regulation of neuroblastoma cells.
- To determine if the inhibitory effect observed in earlier embryos extends to later developmental stages and various embryonic tissues.
- To assess the specificity of this inhibition against other cell types, such as leukemia cells.
Main Methods:
- Organ culture of neuroblastoma cells with embryonic tissues from 13- to 17-day-old embryos.
- Testing inhibitory effects across various embryonic tissues including adrenal gland, testis, kidney, liver, limb bud, and heart.
- Co-culturing neuroblastoma and leukemia cell lines with embryonic tissues.
- Analyzing neuroblastoma colony formation in organ culture.
- Assessing the impact of conditioned media from embryonic limb bud tissue on neuroblastoma cell growth.
Main Results:
- Embryonic tissues from later developmental stages (13-17 days) exhibited a widespread inhibitory effect on neuroblastoma cells across all tested tissues.
- A leukemia cell line was not inhibited by any of the tested embryonic tissues, indicating specificity.
- Neuroblastoma colony formation was inhibited in organ culture.
- Conditioned media from embryonic limb bud tissue slowed, but did not completely stop, neuroblastoma cell growth.
Conclusions:
- Embryonic tissues exert a stage-dependent inhibitory influence on neuroblastoma proliferation, with later stages showing a broader effect.
- The observed inhibition is specific to neuroblastoma cells and not general to all tumor types.
- These findings highlight the potential of embryonic developmental processes to regulate specific cancer cell growth, offering insights for future therapeutic strategies.